Valuation: 3SBio Inc.

Market Cap 33.53B 39.25B 5B 4.36B 4.12B 3.74B 7.01B 480B 7.04B 49.34B 19.04B 244B 18.79B 18.38B 785B P/E 2026 *
14.3x
P/E 2027 * 13.1x
Enterprise Value 22.95B 26.87B 3.42B 2.99B 2.82B 2.56B 4.8B 329B 4.82B 33.78B 13.03B 167B 12.86B 12.58B 538B EV / Sales 2026 *
2.45x
EV / Sales 2027 * 2x
Free-Float
74.62%
Yield 2026 *
1.53%
Yield 2027 * 1.88%
1 day-1.44%
1 week+2.01%
Current month-2.30%
1 month-7.30%
3 months-2.96%
6 months-32.81%
Current year-34.86%
1 week 15.2
Extreme 15.2
16.34
1 month 15.1
Extreme 15.1
18.65
Current year 14.81
Extreme 14.81
29.3
1 year 14.81
Extreme 14.81
35.42
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2006
Director of Finance/CFO 43 03/07/2023
Corporate Officer/Principal 56 27/11/2014
Director TitleAgeSince
Chairman 63 03/04/2012
Director/Board Member 56 11/06/2012
Director/Board Member 57 01/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
9/7/26 A Other

Chief Executive Officer

490,000 0.0193%
7/29/25 A Other

Chief Executive Officer

440,000 0.0184%
4/15/25 A Other

Director

26,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%+2.01%-49.62%+125.32% 5B
-0.58%+0.43%+31.09%-4.81% 78.35B
-2.55%+6.99%+505.27%+47.92% 61.52B
-1.11%+5.08%-11.47%-33.91% 59.78B
+0.14%-1.20%-11.64%+24.21% 46.53B
-0.24%+1.22%+2.26%+151.03% 45.5B
-1.62%-0.76%+49.85%-14.92% 31.84B
-1.81%+3.16%+45.71%+110.57% 25.4B
+0.47%+3.26%-0.77%+142.41% 21.43B
+0.27%+1.96%+62.19%+102.81% 15.77B
Average -0.85%+2.18%+62.29%+65.06% 39.11B
Weighted average by Cap. -0.93%+2.35%+91.68%+41.36%

Financials

2026 *2027 *
Net sales 9.38B 10.98B 1.4B 1.22B 1.15B 1.05B 1.96B 134B 1.97B 13.8B 5.32B 68.25B 5.26B 5.14B 220B 10.01B 11.72B 1.49B 1.3B 1.23B 1.12B 2.09B 143B 2.1B 14.74B 5.69B 72.89B 5.61B 5.49B 235B
Net income 2.34B 2.74B 349M 304M 287M 261M 489M 33.5B 491M 3.44B 1.33B 17.03B 1.31B 1.28B 54.81B 2.63B 3.08B 392M 342M 323M 293M 550M 37.65B 552M 3.87B 1.49B 19.14B 1.47B 1.44B 61.6B
Net Debt -10.58B -12.38B -1.58B -1.38B -1.3B -1.18B -2.21B -151B -2.22B -15.57B -6.01B -77B -5.93B -5.8B -248B -13.55B -15.86B -2.02B -1.76B -1.66B -1.51B -2.83B -194B -2.84B -19.94B -7.69B -98.62B -7.59B -7.43B -317B
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,068
Date Price Change Volume
18/09/26 HK$15.75 -1.44% 15,920,414
17/09/26 HK$15.98 +1.91% 9,587,336
16/09/26 HK$15.68 -2.18% 13,912,889
15/09/26 HK$16.03 -1.17% 10,229,944
14/09/26 HK$16.22 +5.05% 19,604,616
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
13.45CNY
Average target price
26.68CNY
Spread / Average Target
+98.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1530 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!